Loading…
Non-Prescription Drug Modernization Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
2008 · third_quarter · Health Issues
HR 4083, S 2311, non-prescription Drug Act of 2007; determining how to update and improve FDA regulation of OTC drugs
Client expense: Not reported · Firm income: $5,000
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Communications/Broadcasting/Radio/TV
Media Ownership; White Space; DTV cliff; Royalties; Localism; Satellite Home Viewer Extension and Reauthorization Act; S. 2035, Free Flow of Information Act of 2007; S. Con. Res. 82, A concurrent resolution supporting the Local Radio Freedom Act; H. Con. Res. 244, Local Radio Freedom Act; S. 2311, Non-Prescription Drug Modernization Act of 2007; S. 2500, Performance Rights Act; S. 2507, DTV Border Fix Act of 2008; H.R. 5435, DTV Border Fix Act; DTV transition issues; S. 3663, requiring the Federal Communications Commission to provide a short-term extension of the analog television broadcasting transition.
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151, Direct to Consumer Advertising of Drugs
Client expense: $65,235 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $260,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
Legislation and regulations afecting the advertising, marketing and promotion of goods and services | Food Advertising | Prescription Drug Advertising | Children's Advertising | S.334 Healthy Americans Act | S.484 Enhancing Drug Safety and Innovation Act | S. 468 FDA Safety Act | HR 1561 Enhancing Drug Safety and Innovation Act | HR 2117 Health Freedom Protection Act | S 2311 Nonprescription Drug Modernization Act | S 100 Health Students Act | S 948 CAMRA Act |
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Communications/Broadcasting/Radio/TV
Financial Services; Media Ownership; White Space; DTV cliff; Royalties; Congressional Black Caucus letter; National Association of Broadcasters/National Assn. Black Owned Businesses letter; Localism; Satellite Home Viewer Extension and Reauthorization Act; S. 2035, Free Flow of Information Act of 2007; H. J. Res. 79, Disapproving the rule submitted by the Federal Communications Commission with respect to broadcast media ownership; H.R. 5140, Economic Stimulus Act of 2008; S. J. Res. 28, A joint resolution disapproving the rule submitted by the Federal Communications Commission with respect to broadcast media ownership; S. Con. Res. 82, A concurrent resolution supporting the Local Radio Freedom Act; H. Con. Res. 244, Supporting the Local Radio Freedom Act; S. 2311, Non-Prescription Drug Modernization Act of 2007; S. 2500, Performance Rights Act; S. 2507, DTV Border Fix Act of 2008; H.R. 5435, DTV Border Fix Act; S. 2607, DTV Transition Assistance Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151 Direct to Consumer Advertising of Drugs
Client expense: $116,217 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Communications/Broadcasting/Radio/TV
S. 2311, H.R. 4083. Issues concerning advertising of over-the-counter medicines.
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Concerning Pediatric Cough and Cold Medicines; Regulation of over-the-counter medicines. S. 2311 and H.R. 4083.
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R.1561: To amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. H.R.2900: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. H.R.3580: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. H.R.4083: To amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. S.1082: An act to amend the Federal Food, Drug, and cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products, and for other purposes. S.2311: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes.
Client expense: $3,130,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2008 · second_quarter · Health Issues
Pediatric Cough and Cold Medicines; Regulation and Advertising of OTC's, H.R. 4083 and S. 2311 H.R. 6151 Direct to Consumer Advertising of Drugs
Client expense: $150,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
Food Advertising; Prescription Drug Advertising; Children's Advertising; S.334 Healthy Americans Act; S.484 Enhancing Drug Safety and Innovation Act of 2007; S.468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; HR 2117 Health Freedom Protection Act; S 2311 Nonprescription Drug Modernization Act; HR 4083 Nonprescription Drug Modernization Act; S 100 Healthy Students Act of 2007; S 948 CAMRA Act; S. 1031; HR 2045; HR 2633;
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
H.R. 4083/S. 2311 Non-Prescription Drug Modernization Act of 2007; (Amending the FDCA, re: monographs and advertising.)
Client expense: $1,463,960 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Communications/Broadcasting/Radio/TV
S. Con. Res. 82, A concurrent resolution supporting the Local Radio Freedom Act; S.J. Res 28, A joint resolution disapproving the rule submitted by the Federal Communications Commission with respect to broadcast media ownership; S. 2311, Non-Prescription Drug Modernization Act of 2007; S. 2500, Performance Rights Act; S. 2507, DTV Border Fix Act of 2007; S. 2607, DTV Transition Assistance Act; H. Con. Res. 244, Supporting the Local Radio Freedom Act; H.J. Res 79, Disapproving the rule submitted by the Federal Communications Commission with respect to broadcast media ownership; H.R. 3679, State Video Tax Fairness Act of 2007; H.R. 4083, Non-Prescription Drug Modernization Act of 2007; H.R. 4789, Performance Rights Act DTV transition; Campaign Finance Reform; White Space; Performance Tax; Pay for Play; Signal Strength; Performance Rights; Media Ownership; Localism; DTC Drug Advertisements; FCC Appropriations
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,700,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisemetns
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008, H.R.5605 Physician Payments Sunshine Act of 2008, S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE